about
Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: altered working memory and BOLD responseFunctional MRI of mild traumatic brain injury (mTBI): progress and perspectives from the first decade of studiesFunctional MRI and structural MRI as tools for understanding comorbid conditions in children with epilepsy.Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations.Neuroimaging and facial affect processing: implications for traumatic brain injury.Mechanisms of working memory dysfunction after mild and moderate TBI: evidence from functional MRI and neurogenetics.Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives.Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusionStructural and functional magnetic resonance imaging of autism spectrum disordersDopaminergic challenge with bromocriptine one month after mild traumatic brain injury: altered working memory and BOLD responseLong-term seizure, cognitive, and psychiatric outcome following trans-middle temporal gyrus amygdalohippocampectomy and standard temporal lobectomyComparison of manual and automated determination of hippocampal volumes in MCI and early AD.Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot studyLongitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohortBrain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapyLongitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smokingAssociation of cancer history with Alzheimer's disease onset and structural brain changes.Neurocognitive dimensions of breast cancer and its treatmentRecent developments in the application of the nonverbal learning disabilities model.Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel.Cognitive function in breast cancer patients prior to adjuvant treatmentNicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older womenExecutive dysfunction following traumatic brain injury: neural substrates and treatment strategies.Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study.Decreased cerebral blood flow in chronic pediatric mild TBI: an MRI perfusion study.Protective variant for hippocampal atrophy identified by whole exome sequencing.Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults.Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments.Polymorphisms in the brain-derived neurotrophic factor gene influence memory and processing speed one month after brain injuryFunctional neuroanatomical correlates of episodic memory impairment in early phase psychosisReliable change in neuropsychological assessment of breast cancer survivors.Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.Cognitive-behavioral management of chemotherapy-related cognitive change.GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP.Increased working memory-related brain activity in middle-aged women with cognitive complaintsAlterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage.Visual contrast sensitivity in Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints.Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral Neuropathy.Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.
P50
Q24630396-8A791182-19D9-4452-A62E-E78B28840861Q26997913-89475D37-4A02-4C7A-89DE-B5B79FB9DD5FQ30579583-FE186183-0E0F-49E4-9C9B-625028B6197AQ30664513-FD430C6A-41DC-4455-BA57-11F63B7FF1AEQ30722808-3DA0F5E4-26C3-45E0-9678-94E31433FAB7Q31064408-416B42DA-1686-45F4-9D7B-16BAEB02BC01Q33194957-3818E0F3-080F-439B-8E72-BA77729BF153Q33590378-C77982D0-8DCD-438F-B330-A3574259494BQ33763054-E12679D4-6D51-46DC-8891-8B0ADEFB1321Q33819123-A919644E-75AA-4535-AED0-F0054DA53541Q33819176-E063B33D-BD91-4810-935B-89FB771F0E40Q33825551-D8F8A460-3918-4966-9C04-FE829E6B66AFQ33984117-14C43A02-E4F0-453D-AA0F-D9F257B9C521Q33996059-BB32FD22-A89D-43DA-A7B9-2CB9CC755CC9Q34006211-AFBD3F9D-A022-475E-8E8D-ED13C7A9B5D5Q34334920-F1100FE8-E5D3-42B9-BFFD-5DA1045A5B54Q34429393-A91BE5D1-94F6-4896-8617-F00F02DCC8E1Q34433766-A622DE99-CAAE-4FFE-B28A-75E8AF74791FQ34661127-A5E948D4-21F8-45FF-8F06-3EC555CA1192Q34856227-8837512F-6D45-4E9B-986D-898ED0AFE7E1Q34875967-DD017E9E-00A2-478B-953E-D6C297D3A13EQ35043593-C048CCCF-4672-4974-A0D1-D8F3AFCA1421Q35043600-65E55BC5-19F2-4F4D-946C-87C0D8A8F52DQ35053602-609CE88C-7880-40FA-955B-730AA83E0CADQ35204894-56AFBB2D-911D-4C30-BD87-F7CFD081036CQ35283621-1984D4B4-13F8-48B6-BDAB-3BA668FEBAABQ35291942-60DB0EB8-038C-402E-84B3-CCF4AC666115Q35434690-141310D2-97DB-4E8D-8770-F006CC19BAB4Q35882092-B17A3FE6-694E-42B3-BC48-54DF7D59A70BQ35886751-01F535A0-4DDF-455B-90FB-C23E377D9316Q36032824-B5922996-6C10-4B42-A9E5-87B6B7A4DA24Q36087020-D89B7B80-B85C-43BE-BA3A-D5D719E245B0Q36097701-1E6B4277-5A6F-4A2E-B4C0-4E404815E7EAQ36351423-4C19ECEA-920D-44A1-9E4D-3EB7FDF87577Q36351585-47F87C76-E2CF-41BA-A6BF-C171D4EB8B34Q36518293-51168D71-2A99-497B-995C-C1796FF48620Q36528154-A5EDA422-4A11-447B-A8F2-CB1A2D741969Q36532692-A892A4CD-2943-4CB8-832C-FB9333609991Q36770149-FFF9EABD-2E58-4D7D-A52F-43088158A7DFQ36775693-8D5F8763-5ADA-4299-A3FB-1AB8DAD464AA
P50
description
researcher
@en
name
Brenna C. McDonald
@en
Brenna C. McDonald
@es
type
label
Brenna C. McDonald
@en
Brenna C. McDonald
@es
prefLabel
Brenna C. McDonald
@en
Brenna C. McDonald
@es